Patents by Inventor David Parma

David Parma has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tenascin-C nucleic acid ligands
    Publication number: 20060105378
    Abstract: Methods are described for the identification and preparation of nucleic acid ligands to tenascin-C. Included in the invention are specific RNA ligands to tenascin-C identified by the SELEX method. Further included in the invention are methods for detecting the presence of a disease condition in a biological tissue in which tenascin-C is expressed.
    Type: Application
    Filed: December 13, 2005
    Publication date: May 18, 2006
    Applicant: GILEAD SCIENCES, INC.
    Inventors: Brian Hicke, Stephen Warren, David Parma, Larry Gold
  • Tenascin-C nucleic acid ligands
    Patent number: 7005260
    Abstract: Methods are described for the identification and preparation of nucleic acid ligands to tenascin-C. Included in the invention are specific RNA ligands to tenascin-C identified by the SELEX method. Further included in the invention are methods for detecting the presence of a disease condition in a biological tissue in which tenascin-C is expressed.
    Type: Grant
    Filed: January 28, 2000
    Date of Patent: February 28, 2006
    Assignee: Gilead Sciences, Inc.
    Inventors: Brian Hicke, Stephen Warren, David Parma, Larry Gold
  • Tenasin-C nucleic acid ligands
    Publication number: 20040058884
    Abstract: Methods are described for the identification and preparation of nucleic acid ligands to tenascin-C. Included in the invention are specific RNA ligands to tenascin-C identified by the SELEX method. Further included in the invention are methods for detecting the presence of a disease condition in a biological tissue in which tenascin-C is expressed.
    Type: Application
    Filed: May 1, 2003
    Publication date: March 25, 2004
    Inventors: Brian Hicke, Stephen Warren, David Parma, Larry Gold
  • Tenascin-C nucleic acid ligands
    Patent number: 6596491
    Abstract: Methods are described for the identification and preparation of nucleic acid ligands to tenascin-C. Included in the invention are specific RNA ligands to tenascin-C identified by the SELEX method. Further included in the invention are methods for detecting the presence of a disease condition in a biological tissue in which tenascin-C is expressed.
    Type: Grant
    Filed: May 14, 2001
    Date of Patent: July 22, 2003
    Assignee: Gilead Sciences, Inc.
    Inventors: Brian Hicke, Stephen Warren, David Parma, Larry Gold
  • Tenascin-C nucleic acid ligands
    Publication number: 20030104377
    Abstract: Methods are described for the identification and preparation of nucleic acid ligands to tenascin-C. Included in the invention are specific RNA ligands to tenascin-C identified by the SELEX method. Further included in the invention are methods for detecting the presence of a disease condition in a biological tissue in which tenascin-C is expressed.
    Type: Application
    Filed: May 14, 2001
    Publication date: June 5, 2003
    Applicant: Gilead Sciences, Inc.
    Inventors: Brian Hicke, Stephen Warren, David Parma, Larry Gold
  • Tenascin-C nucleic acid ligands
    Patent number: 6232071
    Abstract: Methods are described for the identification and preparation of nucleic acid ligands to tenascin-C. Included in the invention are specific RNA ligands to tenascin-C identified by the SELEX method. Further included in the invention are methods for detecting the presence of a disease condition in a biological tissue in which tenascin-C is expressed.
    Type: Grant
    Filed: July 29, 1999
    Date of Patent: May 15, 2001
    Assignee: Gilead Sciences, Inc.
    Inventors: Brian Hicke, Stephen Warren, David Parma, Larry Gold